Tag Archives: patents

FDA Finalizes Biosimilar Guidance

The Regulatory Affairs Professional Society (RAPS) has posted an informative article “After Three-Year Delay, FDA Finalizes Guidance Documents on Biosimilarity.”  The article includes links to the final guidance documents. You can find the article here.

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | Leave a comment

25 Critical Patent Enforcement Developments

News from Chisum Patent Academy 25 Critical Patent Enforcement Developments The Academy is pleased to announce the April 2015 publication of the annual Update for Volume II (Patent Enforcement) of the practitioner treatise, Mueller on Patent Law, authored by our … Continue reading

Posted in Miscellaneous | Tagged , , , , , , , , | 1 Comment

USPTO Myriad-Mayo Guidance Still Not At An Alpha Standard

This is a guest post from Paul Cole. As readers will be aware, the USPTO published revised Guidance on Section 101 eligibility in December 2014 together with Nature-Based Examples and Abstract ideas examples. These materials and the case-law on which … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | Leave a comment

“Changing The Horizon” Or “Lost Horizon”? – Kappos Pulls It Together

At a meeting sponsored by Intellectual Asset Management (IPBC/Global), “Meeting the NPE Challenge,” former Director of the USPTO, David Kappos on March 13th (a Friday even) gave a speech that cogently summarized the state of the IP landscape both from the … Continue reading

Posted in Miscellaneous | Tagged , , , , , , | 1 Comment